Skip to content
2000
Volume 20, Issue 3
  • ISSN: 1574-8863
  • E-ISSN: 2212-3911

Abstract

Background

Adverse Drug Reactions (ADRs) are unexpected reactions to a medicine administered in the correct manner and at the proper dosage. Drug Rash with Eosinophilia and Systemic Symptoms syndrome (DRESS syndrome) is a Severe Cutaneous Adverse Reaction (SCAR) type of ADR with complicated clinical features involving several organ systems of the body; frequently involved organs are the liver, kidney, lungs, and other organs. Prompt recognition and correct diagnosis, followed by withdrawal of the causative agent, can promote appropriate treatment, accelerate recovery, and reduce the related morbidity and mortality.

Case presentation

We have, herein, presented a case of a 42-year-old female with a history of leflunomide intake for plantar fasciitis. The patient subsequently developed fever, gastrointestinal tract disturbance, facial edema, liver injury, skin rash, hematologic abnormalities (eosinophilia), hepatosplenomegaly, and lymph node enlargement. The probability of leflunomide-induced DRESS syndrome was rated as “definite”, with with a score of eight graded by RegiSCAR. The suspected causative agent was withdrawn, and the patient was managed symptomatically. Following her management and discharge, she again encountered similar complaints after administration of the cefuroxime tablet. The causality assessment of the reactions was done using the WHO-UMC scale and Naranjo’s assessment scale, and a “probable” reaction was found for both drugs.

Conclusion

The presented case contributes to the existing global literature regarding exceptional clinical presentations. Leflunomide and cefuroxime drugs have the potential to cause DRESS syndrome. Thus, they should be handled cautiously, and if such a reaction occurs, it should be reported to the responsible authorities.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cds/10.2174/0115748863321106240903111048
2024-09-19
2025-09-17

  • From This Site

    /content/journals/cds/10.2174/0115748863321106240903111048
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. CabañasR. RamírezE. SendagortaE. AlamarR. BarrancoR. Blanca-LópezN. DoñaI. FernándezJ. Garcia-NunezI. García-SamaniegoJ. Lopez-RicoR. Marín-SerranoE. MéridaC. MoyaM. Ortega-RodríguezN.R. Rivas BecerraB. Rojas-Perez-EzquerraP. Sánchez- GonzálezM.J. Vega-CabreraC. Vila-AlbeldaC. BellónT. Spanish guidelines for diagnosis, management, treatment, and prevention of Dress syndrome.J. Investig. Allergol. Clin. Immunol.202030422925310.18176/jiaci.048031932268
     [Google Scholar]
  2. ShamnaM. DilipC. AjmalM. Linu MohanP. ShinuC. JaferC.P. MohammedY. A prospective study on Adverse Drug Reactions of antibiotics in a tertiary care hospital.Saudi Pharm. J.201422430330810.1016/j.jsps.2013.06.00425161373
     [Google Scholar]
  3. SasiS. AltarawnehH. PetkarM.A. NairA.P. Drug reaction with eosinophilia and systemic symptoms secondary to naproxen: A case report and literature review.Case Rep. Acute Med.202032637210.1159/000509712
     [Google Scholar]
  4. ThappaD.M. KumariR. TimshinaD.K. Drug hypersensitivity syndrome.Indian J. Dermatol. Venereol. Leprol.201177171510.4103/0378‑6323.7496421220873
     [Google Scholar]
  5. ParajuliS. ChaudharyD. PandeyS. BaralS. PokhrelD.B. Leflunomide induced dress syndrome: A case report.NJDVL2012101464810.3126/njdvl.v10i1.6423
     [Google Scholar]
  6. SultanS.J. SameemF. AshrafM. Drug reaction with eosinophilia and systemic symptoms: manifestations, treatment, and outcome in 17 patients.Int. J. Dermatol.201554553754210.1111/ijd.1233124738653
     [Google Scholar]
  7. RaoS. SunkaraA. SrivastavaN. SampatP. RamosC. AlbertE. An uncommon presentation of dress syndrome secondary to leflunomide use: A case report.J. Investig. Med. High Impact Case Rep.2021910.1177/232470962199728233629602
     [Google Scholar]
  8. ShioharaT. InaokaM. KanoY. Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses.Allergol. Int.20065511810.2332/allergolint.55.117075280
     [Google Scholar]
  9. RoujeauJ.C. SternR.S. Severe adverse cutaneous reactions to drugs.N. Engl. J. Med.1994331191272128510.1056/NEJM1994111033119067794310
     [Google Scholar]
  10. ShenoyP. ShanojK.C. JosephS. Drug reaction with eosinophilia and systemic symptoms syndrome.Indian J. Rheumatol.20191455910.4103/0973‑3698.272151
     [Google Scholar]
  11. ChenY.C. ChiuH.C. ChuC.Y. Drug reaction with eosinophilia and systemic symptoms: A retrospective study of 60 cases.Arch. Dermatol.2010146121373137910.1001/archdermatol.2010.19820713773
     [Google Scholar]
  12. DengD. ZhouJ. LiM. LiS. TianL. ZouJ. WangT. WuJ. ZengF. YangJ. Leflunomide monotherapy versus combination therapy with conventional synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis: A retrospective study.Sci. Rep.20201011233910.1038/s41598‑020‑69309‑z32704073
     [Google Scholar]
  13. Electronic medicines compendium.2022Available from: https://www.medicines.org.uk/emc/product/4943/smpc#gref (Accessed on : 16 Jul 2024).
  14. PerryC.M. BrogdenR.N. Cefuroxime Axetil.Drugs199652112515810.2165/00003495‑199652010‑000098799689
     [Google Scholar]
  15. YıldırımY. KaraA.V. YılmazZ. YıldırımR. YılmazS. KadirogluA.K. YilmazM.E. Cefuroxime Axetil Related DRESS (drug reaction with eosinophilia and systemic symptoms) Syndrome.Electron J Gen Med201613210.15197/ejgm.1462
     [Google Scholar]
  16. SinghA. GainderS. Cefuroxime axetil induced DRESS in a pregnant patient.New Ind. J. Obgyn202310121521710.21276/obgyn.2023.10.1.38
     [Google Scholar]
  17. Indian Pharmacopoeia CommissionNational Coordination Centre-Pharmacovigilance Programme of India2022Available from: https://www.ipc.gov.in/images/Drug_Safety_Alert_April_2022. pdf (Accessed on: 05 Jul 2024).
    [Google Scholar]
  18. ShearN.H. SpielbergS.P. GrantD.M. TangB.K. KalowW. Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity.Ann. Intern. Med.1986105217918410.7326/0003‑4819‑105‑2‑1793729200
     [Google Scholar]
  19. Choquet-KastylevskyG. IntratorL. ChenalC. BocquetH. RevuzJ. RoujeauJ.C. Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome.Br. J. Dermatol.199813961026103210.1046/j.1365‑2133.1998.02559.x9990366
     [Google Scholar]
  20. KardaunS.H. SidoroffA. Valeyrie-AllanoreL. HalevyS. DavidoviciB.B. MockenhauptM. RoujeauJ.C. Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?Br. J. Dermatol.2007156360961110.1111/j.1365‑2133.2006.07704.x17300272
     [Google Scholar]
  21. ChenY.C. ChangC.Y. ChoY.T. ChiuH.C. ChuC.Y. Reply to: “Using a diagnostic score when reporting the long-term sequelae of the drug reaction with eosinophilia and systemic symptoms”.J. Am. Acad. Dermatol.20136961060106210.1016/j.jaad.2013.08.02624238172
     [Google Scholar]
  22. LiE. TamL.S. TomlinsonB. Leflunomide in the treatment of rheumatoid arthritis.Clin. Ther.200426444745910.1016/S0149‑2918(04)90048‑315189743
     [Google Scholar]
  23. FatimaM. AzimiS.S. AshwiniS. RadhakrishnaM.H. Leflunomide induced atypical dress: A case report and literature review.Mediterr. J. Rheumatol.2023341919610.31138/mjr.34.1.9137223589
     [Google Scholar]
  24. VaishAK TripathiAK GuptaLK JainN AgarwalA VermaSK An unusual case of DRESS syndrome due to leflunomide.BMJ Case Rep.20112011bcr062011433010.1136/bcr.06.2011.4330
     [Google Scholar]
  25. MansourK. Ben FadhelN. Ben FredjN. Ben RomdhaneH. ChaabaneA. ChadliZ. AouamK. Cefotaxime-induced drug reaction with eosinophilia and systemic symptom in a child with cross-reactivity to other cephalosporins and cosensitization to teicoplanin.Br. J. Clin. Pharmacol.202389254455010.1111/bcp.1541935610175
     [Google Scholar]
  26. AouamK. ChaabaneA. ToumiA. Ben FredjN. Ben RomdhaneF. BoughattasN.A. ChakrounM. Drug rash with eosinophilia and systemic symptoms (DRESS) probably induced by cefotaxime: A report of two cases.Clin. Med. Res.2012101323510.3121/cmr.2011.99521817121
     [Google Scholar]
  27. BabuT. PanachiyilG.M. SebastianJ. ShastryV. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome probably related to cefpodoxime: a case report.J. Pharm. Pract.202134116316510.1177/089719001986609431382812
     [Google Scholar]
  28. ChavanR.B. BelgaumkarV.A. DeshmukhN.S. PatilA. JoshiV.D. Cephalosporin-induced atypical DRESS syndrome; a tale of two cases.Journal of Skin and Stem Cell20218110.5812/jssc.112575
     [Google Scholar]
  29. GaigP. García-OrtegaP. BaltasarM. BartraJ. Drug neosensitization during anticonvulsant hypersensitivity syndrome.J. Investig. Allergol. Clin. Immunol.200616532132617039674
     [Google Scholar]
  30. MullerP. DubreilP. MahéA. LamauryI. SalzerB. DeloumeauxJ. StrobelM. Drug hypersensitivity syndrome in a West-Indian population.Eur. J. Dermatol.200313547848114693494
     [Google Scholar]
  31. World Health Organization (WHO)-Uppsala Monitoring Centre. The use of the WHO-UMC system for standardized case causality assessment.Available from: https://who-umc.org/media/164200/who-umc-causality-assessment_new-logo.pdf (Accessed on : 15 Apr 2022).
  32. NaranjoC.A. BustoU. SellersE.M. SandorP. RuizI. RobertsE.A. JanecekE. DomecqC. GreenblattD.J. A method for estimating the probability of adverse drug reactions.Clin. Pharmacol. Ther.198130223924510.1038/clpt.1981.1547249508
     [Google Scholar]
  33. ChuE.C.P. HuangK.H.K. CheungG. NgG. LinA. Delayed skin allergy to glucosamine chondroitin supplement.Cureus2023153e3631010.7759/cureus.3631036941906
     [Google Scholar]
  34. WattsT.J. HaqueR. DRESS syndrome induced by ranitidine.J. Allergy Clin. Immunol. Pract.2018631030103110.1016/j.jaip.2017.09.01929102410
     [Google Scholar]
  35. YooS.D. KimS.G. KimS.H. KimH. Drug rash with eosinophilia and systemic symptoms syndrome induced by chloral hydrate in early childhood.Allergy Asthma Immunol. Res.20146327027210.4168/aair.2014.6.3.27024843805
     [Google Scholar]
  36. CorneliH.M. Dress syndrome: Drug reaction with eosinophilia and systemic symptoms.Pediatr. Emerg. Care201733749950210.1097/PEC.000000000000118828665896
     [Google Scholar]
  37. FatimaM. AzimiS.S. AshwiniS. RadhakrishnaM.H. Case series on dress: An unpredictable adverse drug reaction.Mediterr. J. Rheumatol.202334224525110.31138/mjr.34.2.24537654627
     [Google Scholar]
  38. HartwigS.C. SiegelJ. SchneiderP.J. Preventability and severity assessment in reporting adverse drug reactions.Am. J. Health Syst. Pharm.19924992229223210.1093/ajhp/49.9.22291524068
     [Google Scholar]
  39. SchumockG.T. ThorntonJ.P. Focusing on the preventability of adverse drug reactions.Hosp Pharm.1992276538
     [Google Scholar]
/content/journals/cds/10.2174/0115748863321106240903111048
Loading
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome with Multiple Drugs (Leflunomide and Cefuroxime): A Case Report
Curr Drug Saf 20, 388 (2025); https://doi.org/10.2174/0115748863321106240903111048
/content/journals/cds/10.2174/0115748863321106240903111048
/content/journals/cds/10.2174/0115748863321106240903111048
Loading

Data & Media loading...


  • Article Type:     Case Report
Keyword(s): cefuroxime; Drug reaction with eosinophilia and systemic symptoms syndrome; drug-induced adverse drug reactions; leflunomide; regiSCAR scoring; severe cutaneous adverse reaction

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test